Altimmune terminates Lonza manufacturing agreement for AdCOVID program

Altimmune, Inc.

Terminated Master Services Agreement with Lonza Houston Inc. dated November 5, 2020.
Associated SOW provided for dedicated manufacturing suite for AdCOVID clinical/commercial supply.
Termination effective December 17, 2021, following prior discontinuation of AdCOVID program (June 29, 2021).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.